pharma · Melanoma · HIV Infections
Bristol Myers Squibb
Bristol-Myers Squibb
NovaPharmaNews editorial coverage mentioning Bristol Myers Squibb — regulatory, clinical, and market analysis.
Company details
- Status
- Public
- HQ
- 3401 Princeton Pike, Lawrence Township, NJ 08648, US
- Employees
- 38,146
- Programs
- 40
- Drugs
- 17
- Patents
- 25
News & analysis
NovaPharmaNews articles mentioning Bristol Myers Squibb — regulatory, clinical, and market coverage.
NovaPharmaNews editorial coverage mentioning Bristol Myers Squibb — regulatory, clinical, and market analysis.
Fierce Pharma Asia: BMS-Hengrui's $15B Deal and More
Bristol Myers Squibb and Hengrui's $15B deal marks a significant shift in oncology investments. Meanwhile, Takeda announces major layoffs affecting 4,500 employees.
Fierce Pharma Asia: Major Developments in Oncology and Workforce Changes
This article covers significant developments in the pharmaceutical sector, including BMS's $15B deal with Hengrui, Takeda's workforce reductions, and Daiichi's oncology initiatives.